You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 1, January 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Transplant site affects splenic T- and B-cell survival and function

C. D. Livingston, M. P. Moyer, B. A. Levine and K. R. Sirinek

We killed control animals and those with intraperitoneal and subcutaneous splenic autotransplants at intervals of up to one year to study gross, microscopic, and immunologic characteristics that might explain previously observed experimental variations in protection against postsplenectomy sepsis. Lymphocyte cell populations were studied qualitatively using concanavalin A (ConA)--and phytohemagglutinin--stimulated tritiated thymidine incorporation, and quantitatively by immunofluorescence assay. Subcutaneous implants showed fibrosis and lost mass, which was reflected in reduced numbers of functional B- and T-cell lymphocytes. Intraperitoneal implants grew during the observation period and demonstrated normal numbers of functional B- and T-cell lymphocytes. Previous experimental results showing protection against postsplenectomy sepsis following intraperitoneal but not subcutaneous autotransplantation may be the result of maintaining normal numbers of functional lymphocytes in the transplanted splenic tissue rather than a qualitative change in cellular function.





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.